Aimei Health Technology Co., Ltd (NASDAQ:AFJK – Get Free Report) was the recipient of a significant decline in short interest during the month of November. As of November 15th, there was short interest totalling 1,000 shares, a decline of 56.5% from the October 31st total of 2,300 shares. Currently, 0.0% of the company’s stock are short sold. Based on an average daily volume of 34,200 shares, the days-to-cover ratio is presently 0.0 days.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently bought and sold shares of the business. Virtu Financial LLC purchased a new stake in shares of Aimei Health Technology in the third quarter valued at $123,000. Clear Street LLC acquired a new stake in shares of Aimei Health Technology in the second quarter valued at about $575,000. Shaolin Capital Management LLC grew its stake in shares of Aimei Health Technology by 33.3% in the second quarter. Shaolin Capital Management LLC now owns 400,000 shares of the company’s stock valued at $4,140,000 after buying an additional 100,000 shares in the last quarter. Mizuho Securities USA LLC boosted its holdings in Aimei Health Technology by 60.7% in the third quarter. Mizuho Securities USA LLC now owns 442,778 shares of the company’s stock valued at $4,627,000 after purchasing an additional 167,223 shares during the last quarter. Finally, Wolverine Asset Management LLC boosted its holdings in Aimei Health Technology by 8.9% in the second quarter. Wolverine Asset Management LLC now owns 496,196 shares of the company’s stock valued at $5,136,000 after purchasing an additional 40,598 shares during the last quarter. Institutional investors and hedge funds own 45.58% of the company’s stock.
Aimei Health Technology Price Performance
AFJK opened at $10.60 on Friday. Aimei Health Technology has a 52 week low of $10.15 and a 52 week high of $10.69. The business’s 50 day moving average is $10.54 and its two-hundred day moving average is $10.44.
Aimei Health Technology Company Profile
Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors.
Further Reading
- Five stocks we like better than Aimei Health Technology
- NYSE Stocks Give Investors a Variety of Quality OptionsĀ
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- Using the MarketBeat Dividend Tax Calculator
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- What Are Dividend Contenders? Investing in Dividend Contenders
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for Aimei Health Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aimei Health Technology and related companies with MarketBeat.com's FREE daily email newsletter.